2025
CASE STUDY
BIOTECH
Trusted by:
... and many others
The Goal was to create a 2D explainer video showcasing the HER2-VLP vaccine’s mechanism and its effectiveness against HER2-overexpressing tumors compared to traditional treatments.
The video was primarily developed for investors, but also for other stakeholders to differentiate the technology.
The style of the video should match the newly refreshed website.
ExpreS2ion Biotech is a biotechnology company specializing in the development of innovative protein-based vaccines and therapeutics.
Project scope
The 40-second animation explains how HER2-overexpression leads to tumor growth, how the HER2-VLP vaccine works, and how it enhances immune response by generating a stronger and more durable attack on cancer cells compared to standard treatments.
1
meeting
Communication with client is essential for us. To listen to them and provide with the best result
2
rounds
Two feedback rounds on each milestone of the production stage
Claryfiying requirements
Scientific materials, proceeding
Frames drawing
Pre-final/final video delivering
Development of the preliminary video scenario.
Providing the draft video
Providing final video, .mp4, FullHD, 1920x1080
8
weeks
Duration from the idea to the final delivery of the video (59 sec)
WEEK 8
WEEK 1
WEEK 3
WEEK 5
Storyboard development
Creative concept
creation
Animation creation
Thank you to you and your team for the great work!
Keith Alexander
Chief Financial Officer
nanobotmedical.com
EU & US based,
operating globally since 2016
4.9/5
customer satisfaction
2010 first scientific videos were developed
Our mission:
to help bring 100 Impactful products/ideas to market by 2030 (6 years!).
15
years of expertise in scientific communications
500+
successful projects
1000+
minutes of scientific video
20 +
highly skilled professionals, 3 PhD level colleagues
100+
pitch decks and sales aids
and many more....
Andrii Koniukh
Co-Founder and CEO
EU •
Yurii Svidinenko
Co-Founder and Production director
US •